ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,120 | -11.7% | 4,000 | 0.0% | 0.00% | – |
| Q2 2023 | $9,200 | -24.1% | 4,000 | 0.0% | 0.00% | – |
| Q1 2023 | $12,120 | +30.0% | 4,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,320 | -6.8% | 4,000 | -20.0% | 0.00% | – |
| Q3 2022 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -33.3% | 5,000 | -28.6% | 0.00% | – |
| Q1 2022 | $21,000 | -22.2% | 7,000 | 0.0% | 0.00% | – |
| Q4 2021 | $27,000 | -10.0% | 7,000 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $30,000 | +42.9% | 7,000 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -100.0% | 7,000 | -50.0% | 0.00% | – |
| Q1 2021 | $46,620,000 | +186380.0% | 14,000 | +100.0% | 0.00% | -100.0% |
| Q4 2020 | $25,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,510,223 | $19,727,000 | 1.35% |
| Foresite Capital Management IV, LLC | 804,446 | $2,880,000 | 1.04% |
| EcoR1 Capital, LLC | 2,172,883 | $7,779,000 | 0.72% |
| DAFNA Capital Management LLC | 246,900 | $884,000 | 0.38% |
| BAILARD, INC. | 228,000 | $816,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,765,415 | $6,320,000 | 0.05% |
| Seelaus Asset Management LLC | 14,300 | $51,000 | 0.05% |
| Hudson Bay Capital Management LP | 650,000 | $2,327,000 | 0.03% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,040,900 | $14,466,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 71,560 | $256,000 | 0.01% |